SHOT/CHASER: Greg Gianforte complains about price gouging/profits from price gouging

SHOT: In a recent interview with Montana Public Radio, New Jersey multi-millionaire Greg Gianforte complained about price gouging by pharmaceutical companies.
Take a listen...
[7:24"They're very high and we've seen gouging by prescription drugs. If we're gonna give a pharmaceutical company a monopoly on a drug, they have an obligation not to gouge a customer."

CHASER: Greg Gianforte owns millions in pharmaceutical stocks and directly benefits from price gouging.

Greg Gianforte owns $2.5 million in stock in 12 pharmaceutical companies including Bristol Myers Squibb, Pfizer, Merck & Company Inc., CSL, Abbvie, Novartis, Novo Nordisk, Shire PLC, Takeda, Taro Pharmaceutical industries, Allergan PLC and Bayer AG. The companies have come under fire for inflating drug prices, increasing health care costs for hard-working Americans. In addition, many of Gianforte’s companies have lobbied against changing the way Medicare reimburses doctors for expensive drugs, which has resulted in increased costs for seniors.


Stay Informed

Sign Up to Get News and Action Alerts